The health-system benefits and cost-effectiveness of using Mycobacterium tuberculosis direct nucleic acid amplification testing to diagnose tuberculosis disease in the United States.

The health-system benefits and cost-effectiveness of using Mycobacterium tuberculosis direct nucleic acid amplification testing to diagnose tuberculosis disease in the United States. Clin Infect Dis. 2013 Aug; 57(4):532-42.

View in: PubMed

subject areas

Adolescent
Adult
Aged
Aged, 80 and over
Child
Child, Preschool
Cohort Studies
Cost-Benefit Analysis
Female
Humans
Infant
Infant, Newborn
Male
Middle Aged
Molecular Diagnostic Techniques
Mycobacterium tuberculosis
Nucleic Acid Amplification Techniques
Retrospective Studies
Time Factors
Tuberculosis, Pulmonary
United States
Young Adult

authors with profiles

Susan Dorman